Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Video

Delayed Pericardial Effusion Following LAA Closure: The Auto-Tug Phenomenon

Akhil Mogalapalli, MD
Sundeep Kumar, MD
Tabitha Lobo, MD
Joseph Reed, MD
Luis Augusto Palma Dallan, MD, PhD
Sung-Han Yoon, MD
Steven J. Filby, MD
11/30/2022

Related Content

Clinical Images
Role of Diastology in Transcatheter Aortic Valve Implantation
02/24/2018
Transient elevation of LV diastolic pressure above LA pressure can occur in severe aortic regurgitation in the diastasis phase. Mitral E wave reversal in such a situation could serve as non-invasive evidence of elevated left ventricular...
Transient elevation of LV diastolic pressure above LA pressure can occur in severe aortic regurgitation in the diastasis phase. Mitral E wave reversal in such a situation could serve as non-invasive evidence of elevated left ventricular...
Transient elevation of LV...
02/24/2018
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement

News

Microvascular Disease
Hourglass-Shaped Stent Could Ease Severe Chest Pain From Microvascular Disease
11/08/2024
The different design is thought to increase back pressure, redistributing blood flow more fully through small vessels in the heart that were not working at capacity.
The different design is thought to increase back pressure, redistributing blood flow more fully through small vessels in the heart that were not working at capacity.
The different design is thought...
11/08/2024
Cath Lab Digest
Peripheral IVL
DISRUPT BTK II: Shockwave Medical Further Validates Utility of Intravascular Lithotripsy in Lower Limb Lesions in Late-Breaking Presentation at VIVA 2024
11/08/2024
DISRUPT BTK II's primary effectiveness endpoint of procedural success, defined as ≤50% residual stenosis for all treated target lesions without serious angiographic complications, was met with a rate of 97.9% at 30 days.
DISRUPT BTK II's primary effectiveness endpoint of procedural success, defined as ≤50% residual stenosis for all treated target lesions without serious angiographic complications, was met with a rate of 97.9% at 30 days.
DISRUPT BTK II's primary...
11/08/2024
Cath Lab Digest
Peripheral IVL
Shockwave Medical Unveils First Clinical Outcomes of New IVL Platform in Late-Breaking Presentation at VIVA 2024
11/08/2024
The Shockwave Javelin Peripheral IVL Catheter is a novel, non-balloon-based lithotripsy platform. Despite the challenging nature of the calcified lesions studied, the 30-day study results met both prespecified performance goals while showing...
The Shockwave Javelin Peripheral IVL Catheter is a novel, non-balloon-based lithotripsy platform. Despite the challenging nature of the calcified lesions studied, the 30-day study results met both prespecified performance goals while showing...
The Shockwave Javelin Peripheral...
11/08/2024
Cath Lab Digest
Scaffolds for BTK
Late-Breaking Data Shows Sustained Benefits of Abbott's Esprit™ BTK System for People Battling PAD Below the Knee
11/04/2024
The Esprit BTK System is a first-of-its-kind dissolvable stent to treat PAD below the knee. It is comprised of material similar to dissolving sutures that helps heal the vessel once the blockage is opened and provides support until the vessel...
The Esprit BTK System is a first-of-its-kind dissolvable stent to treat PAD below the knee. It is comprised of material similar to dissolving sutures that helps heal the vessel once the blockage is opened and provides support until the vessel...
The Esprit BTK System is a...
11/04/2024
Cath Lab Digest
elective surgery post MI
Researchers Identify 'Sweet Spot' for Safe Surgery After Heart Attack
11/04/2024
"The data physicians are using for patient care decisions today is outdated. Given the advances in care and the ever-changing mix of patients, clinicians need the latest information," said Laurent Glance, MD. The recommendation was based on a...
"The data physicians are using for patient care decisions today is outdated. Given the advances in care and the ever-changing mix of patients, clinicians need the latest information," said Laurent Glance, MD. The recommendation was based on a...
"The data physicians are using...
11/04/2024
Cath Lab Digest
reimbursement
Elucid Announces CCTA Reimbursement to Be Doubled With CMS Rule
11/04/2024
Those decisions further recognize the importance of new technologies like Elucid’s PlaqueIQ™ that can help non-invasively quantify and classify coronary artery plaque and its components such as lipid-rich necrotic core (LRNC), giving...
Those decisions further recognize the importance of new technologies like Elucid’s PlaqueIQ™ that can help non-invasively quantify and classify coronary artery plaque and its components such as lipid-rich necrotic core (LRNC), giving...
Those decisions further...
11/04/2024
Cath Lab Digest
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
IVL + Laser Atherectomy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single Device to Treat PAD
11/04/2024
Royal Philips announced enrollment of the first patient in the U.S. THOR IDE clinical trial, which will study an innovative combined laser atherectomy and intravascular lithotripsy catheter developed by Philips that integrates two critical...
Royal Philips announced enrollment of the first patient in the U.S. THOR IDE clinical trial, which will study an innovative combined laser atherectomy and intravascular lithotripsy catheter developed by Philips that integrates two critical...
Royal Philips announced...
11/04/2024
Cath Lab Digest
Renal Denervation
Recor Medical Announces CMS Grant of Transitional Pass-Through (TPT) Payment for Recor’s Paradise Ultrasound Renal Denervation System for the Treatment of Uncontrolled Hypertension
11/04/2024
The Paradise uRDN system is an ultrasound-based RDN technology designed to lower blood pressure by denervating the sympathetic nerves surrounding the renal arteries, reducing the overactivity that can lead to hypertension.
The Paradise uRDN system is an ultrasound-based RDN technology designed to lower blood pressure by denervating the sympathetic nerves surrounding the renal arteries, reducing the overactivity that can lead to hypertension.
The Paradise uRDN system is an...
11/04/2024
Cath Lab Digest
Bioresorbable Scaffolds
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of Its Magnitude Drug-Eluting Next-Generation Bioresorbable Scaffold for BTK PAD
11/04/2024
Eric A. Secemsky, MD, MSc, lead investigator for the ELITE-BTK pivotal trial, said, “This is a much-anticipated trial given the advancements and advantages of this next-generation technology which has the potential to transform the field of...
Eric A. Secemsky, MD, MSc, lead investigator for the ELITE-BTK pivotal trial, said, “This is a much-anticipated trial given the advancements and advantages of this next-generation technology which has the potential to transform the field of...
Eric A. Secemsky, MD, MSc, lead...
11/04/2024
Cath Lab Digest

Advertisement

Advertisement

Microvascular Disease
Hourglass-Shaped Stent Could Ease Severe Chest Pain From Microvascular Disease
11/08/2024
The different design is thought to increase back pressure, redistributing blood flow more fully through small vessels in the heart that were not working at capacity.
The different design is thought to increase back pressure, redistributing blood flow more fully through small vessels in the heart that were not working at capacity.
The different design is thought...
11/08/2024
Cath Lab Digest
Peripheral IVL
DISRUPT BTK II: Shockwave Medical Further Validates Utility of Intravascular Lithotripsy in Lower Limb Lesions in Late-Breaking Presentation at VIVA 2024
11/08/2024
DISRUPT BTK II's primary effectiveness endpoint of procedural success, defined as ≤50% residual stenosis for all treated target lesions without serious angiographic complications, was met with a rate of 97.9% at 30 days.
DISRUPT BTK II's primary effectiveness endpoint of procedural success, defined as ≤50% residual stenosis for all treated target lesions without serious angiographic complications, was met with a rate of 97.9% at 30 days.
DISRUPT BTK II's primary...
11/08/2024
Cath Lab Digest
Peripheral IVL
Shockwave Medical Unveils First Clinical Outcomes of New IVL Platform in Late-Breaking Presentation at VIVA 2024
11/08/2024
The Shockwave Javelin Peripheral IVL Catheter is a novel, non-balloon-based lithotripsy platform. Despite the challenging nature of the calcified lesions studied, the 30-day study results met both prespecified performance goals while showing...
The Shockwave Javelin Peripheral IVL Catheter is a novel, non-balloon-based lithotripsy platform. Despite the challenging nature of the calcified lesions studied, the 30-day study results met both prespecified performance goals while showing...
The Shockwave Javelin Peripheral...
11/08/2024
Cath Lab Digest
Original Contribution
Utility of Balloon-Expandable Covered Stent Graft Endoprosthesis in Congenital Heart Disease
11/07/2024
The authors describe their early experience with the VIABAHN VBX balloon expandable endoprosthesis (Gore), a premounted, balloon expandable, covered stent graft in children with congenital heart disease.
The authors describe their early experience with the VIABAHN VBX balloon expandable endoprosthesis (Gore), a premounted, balloon expandable, covered stent graft in children with congenital heart disease.
The authors describe their early...
11/07/2024
Journal of Invasive Cardiology
TCT image
TCT Conference Coverage
TCT 2024 Highlights with Dr. Deepak L. Bhatt
11/07/2024
Dr Deepak L. Bhatt, editor-in-chief of the Journal of Invasive Cardiology, shares highlights from TCT 2024.
Dr Deepak L. Bhatt, editor-in-chief of the Journal of Invasive Cardiology, shares highlights from TCT 2024.
Dr Deepak L. Bhatt,...
11/07/2024
Journal of Invasive Cardiology
Ku Figure
Clinical Videos
Traumatic Giant Renal Arteriovenous Fistula
11/06/2024
Video Supplement to "Traumatic Giant Renal Arteriovenous Fistula" (Clinical Image).
Video Supplement to "Traumatic Giant Renal Arteriovenous Fistula" (Clinical Image).
Video Supplement to "Traumatic...
11/06/2024
Journal of Invasive Cardiology
Clinical Images
Traumatic Giant Renal Arteriovenous Fistula
11/06/2024
A 46-year-old man presented with bilateral lower extremity edema for more than 3 months. He had a history of bruising to the left abdominal area as a result of a motorcycle accident several years ago.
A 46-year-old man presented with bilateral lower extremity edema for more than 3 months. He had a history of bruising to the left abdominal area as a result of a motorcycle accident several years ago.
A 46-year-old man presented with...
11/06/2024
Journal of Invasive Cardiology
Erratum
Correction to: Same-Day Discharge After Elective Percutaneous Coronary Intervention for Chronic Total Occlusion in the UK
11/06/2024
© 2024 HMP Global. All Rights Reserved. Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the Journal of Invasive Cardiology or HMP Global, their...
© 2024 HMP Global. All Rights Reserved. Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the Journal of Invasive Cardiology or HMP Global, their...
© 2024 HMP Global. All Rights...
11/06/2024
Journal of Invasive Cardiology
Clinical Images
Percutaneous Closure of Pulmonary Arteriovenous Malformation and Concomitant Patent Foramen Ovale for Cryptogenic Stroke
11/04/2024
A 64-year-old woman presented with acute onset left-sided facial droop, left upper extremity paresis, and aphasia. Magnetic resonance imaging demonstrated acute infarction of the right thalamus.
A 64-year-old woman presented with acute onset left-sided facial droop, left upper extremity paresis, and aphasia. Magnetic resonance imaging demonstrated acute infarction of the right thalamus.
A 64-year-old woman presented...
11/04/2024
Journal of Invasive Cardiology
Scaffolds for BTK
Late-Breaking Data Shows Sustained Benefits of Abbott's Esprit™ BTK System for People Battling PAD Below the Knee
11/04/2024
The Esprit BTK System is a first-of-its-kind dissolvable stent to treat PAD below the knee. It is comprised of material similar to dissolving sutures that helps heal the vessel once the blockage is opened and provides support until the vessel...
The Esprit BTK System is a first-of-its-kind dissolvable stent to treat PAD below the knee. It is comprised of material similar to dissolving sutures that helps heal the vessel once the blockage is opened and provides support until the vessel...
The Esprit BTK System is a...
11/04/2024
Cath Lab Digest

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement